25 related articles for article (PubMed ID: 16226344)
1. Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex.
Storer RJ; Akerman S; Goadsby PJ
Br J Pharmacol; 2003 Jan; 138(2):317-24. PubMed ID: 12540522
[TBL] [Abstract][Full Text] [Related]
2. The amino-terminal heptapeptide of the algesic substance P provides analgesic effect in relieving chronic neuropathic pain.
Nyman J; Guo N; Sandström A; Hallberg M; Nyberg F; Yu L
Eur J Pharmacol; 2021 Feb; 892():173820. PubMed ID: 33345847
[TBL] [Abstract][Full Text] [Related]
3. µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice.
Nisbett KE; Vendruscolo LF; Koob GF
Transl Psychiatry; 2024 Feb; 14(1):125. PubMed ID: 38413576
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and biological study of new synthetic opioid hemorphin-4 peptides containing sterically restricted nonnatural amino acids.
Todorov P; Georgieva S; Trapella C; Chakarov K; Tchekalarova J; Pechlivanova D; Cheshmedzhieva D; Fantinati A; Illuminati D
Arch Pharm (Weinheim); 2024 Apr; ():e2400052. PubMed ID: 38578075
[TBL] [Abstract][Full Text] [Related]
5. Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli.
Beaudry H; Dubois D; Gendron L
J Neurosci; 2011 Sep; 31(37):13068-77. PubMed ID: 21917790
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive and nociceptive actions of opioids.
Ossipov MH; Lai J; King T; Vanderah TW; Malan TP; Hruby VJ; Porreca F
J Neurobiol; 2004 Oct; 61(1):126-48. PubMed ID: 15362157
[TBL] [Abstract][Full Text] [Related]
7. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
8. Involvement of multiple µ-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission.
Mizoguchi H; Takagi H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2014 Jan; 51():15-25. PubMed ID: 24512946
[TBL] [Abstract][Full Text] [Related]
9. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
11. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide FF, pain and analgesia.
Roumy M; Zajac JM
Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
